The latest biotech news

News and Trends 6 Oct 2022

Growing hub Lithuania ready to welcome biotech sector to EFIB’22

On October 26 and 27 the Lithuanian capital, Vilnius, is hosting the European Forum for Industrial Biotechnology & the Bioeconomy 2022 (EFIB’22). EFIB, one of Europe’s top biotech events, will bring together business leaders, entrepreneurs, scientists, and investors. Executive director of the Lithuanian Biotechnology Association, Agnė Vaitkevičienė, explains the importance of EFIB and the potential […]

October 6, 2022 - 5 minutesmins - By Jim Cornall

News and Trends 6 Oct 2022

Catawba College and Eremid open genomics lab to offer undergrad training

Catawba College and Eremid Genomic Services, LLC, a genomics contract research provider, are opening the Bill and Shari Graham Genomics Laboratory specializing in genomic sequencing at Eremid’s facilities on the North Carolina Research Campus (NCRC) in Kannapolis, North Carolina. “The Graham Genomics Lab is an example of the exceptional liberal arts education offered at Catawba […]

October 6, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 6 Oct 2022

Novartis Biome UK Heart Health Catalyst 2022 winners announced

Novartis Pharmaceuticals UK has announced that Xim, creators of Lifelight, and PocDoc are the successful companies of the Novartis Biome UK Heart Health Catalyst 2022, in partnership with Medtronic, RYSE Asset Management, Chelsea and Westminster Hospital NHS Foundation Trust and its official charity CW+. Lifelight and PocDoc will receive support to scale their innovative digital […]

October 6, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 6 Oct 2022

New approaches beckon for small cell lung cancer treatment

Small cell lung cancer (SCLC) is a particularly aggressive tumor that has so far been treated with standardized measures. However, a study led by MedUni Vienna in Austria has shown for the first time that different SCLC subtypes have specific molecular characteristics, which is why those affected respond in different ways to cancer treatment. This […]

October 6, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 5 Oct 2022

Big Idea Ventures announces cohort of 17 start-ups

Big Idea Ventures has revealed its latest accelerator cohort. Seventeen early-stage startups were selected for pre-seed investment as part of Big Idea Ventures’ bi-annual new protein accelerator program. Investments were made through the firm’s three offices in New York, Paris and Singapore and the firm’s first fund – New Protein Fund I ($50 million+). “The […]

October 5, 2022 - 7 minutesmins - By Jim Cornall

News and Trends 5 Oct 2022

FDA fast tracks Immutep non-small cell lung cancer candidate

Immutep Limited says the United States Food and Drug Administration (FDA) has granted fast track designation to eftilagimod alpha (efti or IMP321) in combination with pembrolizumab for the treatment of first line non-small cell lung cancer (NSCLC). Efti is the company’s first-in-class soluble LAG-3 clinical stage candidate, which activates antigen presenting cells (APC) to engage […]

October 5, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 5 Oct 2022

New biotech company aims to bridge gap between stem cell research and athletic injuries

Andrews Medicine of Pensacola, Florida, and Celltex Therapeutics Corporation of Houston, Texas, are to form a new biotechnology company to bridge the divide between stem cell research and the current treatment of athletic injuries. The jointly owned company will operate under the name of Andrews Celltex Biologics. The new company will undertake the operation of […]

October 5, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 5 Oct 2022

Transcenta monoclonal antibody gets FDA clearance

Transcenta Holding Limited says its TST004 humanized monoclonal antibody targeting MASP2, has received IND clearance from the U.S. Food and Drug Administration (FDA). MASP2, mannose-binding protein-associated serine protease 2, is a key enzyme in the lectin pathway initiation of complement activation. Studies have shown that lectin pathway activation contributes to multiple human diseases such as […]

October 5, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 5 Oct 2022

OncoSec slashing staff numbers to prioritize pipeline

OncoSec Medical Incorporated is restructuring to prioritize development of its lead clinical candidate TAVO (TAVO-EP). TAVO is a plasmid encoding interleukin 12 (IL-12) delivered by intratumoral electroporation. Oncosec is reducing its staff by approximately 45% and prioritizing clinical pipeline activities to reduce operating expenses. The company and remaining employees will focus clinical activities in melanoma […]

October 5, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 5 Oct 2022

Intravacc to develop intranasal gonorrhea vaccine with $14.6M NIH/NIAID contract

Intravacc has been awarded a contract with base and options that may total US$14.6 million for the development of a prophylactic intranasal vaccine against Neisseria gonorrhoeae (NG). The contract has been awarded by the US National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), Gonorrhea is a sexually […]

October 5, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 5 Oct 2022

CanSinoBIO to present latest data on inhaled COVID vaccine

CanSino Biologics Inc. will be presenting clinical trial data for the recombinant COVID-19 vaccine (adenovirus type 5 vector) for inhalation (with the trade name Convidecia Air) at World Vaccine Congress (WVC) Europe to be held October 11 to 14, 2022 in Barcelona, Spain. Jean-Denis Shu, vice president for medical affairs of CanSino Biologics will be […]

October 5, 2022 - 2 minutesmins - By Jim Cornall

antibody drug conjugate adc small cancer treatment

News and Trends 5 Oct 2022

Araris Biotech closes $24M financing round for ADCs

Araris Biotech AG, a company pioneering a proprietary antibody-drug conjugate (ADC)-linker technology, today announced the closing of a $24 million financing round, bringing the total funds raised to $40 million to date. The round was co-led by 4BIO Capital and Pureos Bioventures, with participation from new investors, including Wille AG and the Institute for Follicular […]

October 5, 2022 - 2 minutesmins - By Jim Cornall

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

News and Trends

Growing hub Lithuania ready to welcome biotech sector to EFIB’22

Catawba College and Eremid open genomics lab to offer undergrad training

Novartis Biome UK Heart Health Catalyst 2022 winners announced

New approaches beckon for small cell lung cancer treatment

Big Idea Ventures announces cohort of 17 start-ups

FDA fast tracks Immutep non-small cell lung cancer candidate

New biotech company aims to bridge gap between stem cell research and athletic injuries

Transcenta monoclonal antibody gets FDA clearance

OncoSec slashing staff numbers to prioritize pipeline

Intravacc to develop intranasal gonorrhea vaccine with $14.6M NIH/NIAID contract

CanSinoBIO to present latest data on inhaled COVID vaccine

Araris Biotech closes $24M financing round for ADCs

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!